The Swiss Times - Swiss News in English

Resistant bacteria can remain in the body for years

Antibiotic-resistant bacteria can remain in the body for years. Even nine years after an initial illness, researchers from the University of Basel and University Hospital Basel were able to detect resistant bacteria in certain patients.

"These patients can both repeatedly fall ill themselves and also be a source of infection for other people. They therefore represent a reservoir for these pathogens," Aguilar Bultet, lead author of the study, was quoted as saying in a press release issued by the University of Basel on Thursday.

The researchers led by Sarah Tschudin analyzed samples from over 70 people for the study, which was published in the journal "Nature Communications". These were infected with resistant Klebsiella pneumoniae and Escherichia coli bacteria. The focus of the study was on older people with pre-existing conditions.

Even after five or even nine years, the resistant bacteria were still detectable in some of the patients, as the study showed.

According to the University of Basel, this knowledge is crucial for the choice of treatment. This is because it shows that people who have been infected with a resistant bacterium are at risk of standard antibiotics not working in the event of a new infection.


Most Read

Barry Callebaut to Cut 2,500 Jobs

26 February 2024
Barry Callebaut
Barry Callebaut, the world's largest chocolate manufacturer, announces significant job cuts as part of its "BC Next Level" savings plan.

Swiss Electricity Prices to Dip Slightly in 2025, Uvek Reports

29 February 2024
Swiss electricity prices
Swiss Electricity Prices expected to decrease in 2025 as DETEC reduces the capital cost rate for electricity grid investments.

Kuehne+Nagel Stabilise in 2023: Plans For Expansion

1 March 2024
Kuehne+Nagel Future
Kuehne+Nagel normalise growth after corona, despite a downturn, the firm aims for strategic growth and stability.

Swiss Competition Commission: Investigate UBS Now

1 March 2024
Swiss Competition Commission
Swiss Competition Commission seeks an in-depth investigation into UBS after the CS merger, highlighting possible market dominance issues.

Stay in Touch!


Flixbus Total Sales Over Two Billion Euros For the First Time
29 February 2024
Zambon Group
Zambon Group: Exclusive Licensing Deal for IPX203 in Europe
29 February 2024